Connect with us

Health

Matters Arising: Blood Transfusion Services in Nigeria

Published

on

Blood Transfusion

By Saifullahi Attahir

I’m sure once in your life time have experienced or had one of your acquittances received a unit of blood. But have we ever gave a second thought about how this integral part of healthcare system in Nigeria is managed? In this article, I would give the reader a glimpse into this sector due to it’s importance, and some comparison of how it’s manage in other advanced countries.

Blood transfusion was a century old medical practice developed around 1900 by a scientist called Carl landstener, despite several attempts by contemporary scientists before him to devise a means to replace loss of blood encountered by patients either during surgical operations, accidents, or child birth.

Landstener was able to perpect the art of blood transfusion through discovery of major blood groups (ABO, and Rhesus) that played role in matching donor and recipients. Since then, there was continued effort toward safe blood transfusion services across the globe which massively lead to the decline in mortality rate associated with decrease blood supply in the body.

In Nigeria, blood transfusion services was practiced since the colonial-post colonial period mostly starting in Lagos and major urban centres. The major breakthrough was when the National blood transfusion services was established in 2005 during President Obasanjo. The National Health act of 2014 lead to the passage of National blood service Agency bill in 29th /July/ 2021.

According to the NBSA (www.nbsc.gov.ng) site, there was 17 voluntary blood donation centers across the 6 geopolitical zones of Nigeria including separate centers in Federal Capital Abuja, and other centers within the Arm Forces/ Military hospitals. National blood donation day is celebrated every 8th of December, and World safe donation day celebrated every 14th, June.

Nigeria has a population of over 200 million people, and without saying, our demand for blood donation was staggering looking at the number of road traffic accidents, obstetrics patients, major surgical procedures, under 5 years malarial and Schistosomial infections. This is apart from anaemic conditions due to malnutrition (Iron deficiency), other tropical diseases, Chronic Kidney Diseases, abnormal menstruation, and burns.

With all the above mention reasons, our data regarding blood transfusion services was reprehensible.

Several factors have lead to that including community neglect, lack of government intervention, lack of standard private practices, cultural influences, poor funding, and the Almighty mismanagement of resources.

About 1,230, 000 (one million, two hundred and thirty thousand) units/pints of blood are collected annually across Nigeria healthcare facilities, but unfortunately about 90% of this donations are paid commercials. Only 25,000 units are donated by volunteers that are made available to 3,400 hospitals urgent request! This simply shows that less than 5% of blood donation in Nigeria is voluntary.

Let me highlight four different forms of donations practiced worldwide;

* There was voluntary donation done by individuals just for the sake of humanity with no ulterior motive.

*There was direct/replacement donation usually done by relatives of a patients that are called in times of emergency. This one is hugely practice in Nigeria to about 75% in public hospitals.

* There was paid commercial donations in which donors give blood and collect money for it. This practice in Nigeria constitute about 25% in public hospitals and about 75% in some private clinics. This practice carried the major risk of transmitting transfusion-transmitted infections like HIV, Hepatitis B, and C.

* There was the autologous transfusion in which individual give his own blood prior to some surgical operations where the blood is stored, and later transfused back to him. This procedure has the least risk of transmitting infection and eliciting blood transfusion reactions.

Among the four blood transfusion methods, the two most widely practiced in Nigeria are the replacement and the paid commercial. People only care to donate blood when they knew their relatives are in need. This practice was commoner in our society from the villages to the urban. You could donate as soon as you know it’s your parents, wife, son, sister, brother or friend. Any other person can go to hell!

The worst form of practice is the commercial one, where people either out of ignorance or artificial poverty volunteer to donate only if they are going to be paid for it. This business triggers every form of atrocities where the donors sometimes donate multiple times within a short period of time ( The standard is at least an interval of 4-6 months, depending on age, gender, and social status).

The paid donors carries the highest risk of transmitting infections and other abnormalities either to themselves or to the recipients. So this practice need to be discourage by the healthcare personnels and the Government.
As an insider, and with my little period of practice, I have come to realized some of the difficulties blood transfusion services encountered in our health care facilities.

Shortage of blood units

There was the problem of blood supply shortage, this is evident from how Doctors/Lab personnel always advised patient relatives to go home and mobilized their kinsmen when a patient was in need of blood. This happens as if it were the standard thing to do. The ideal is for a patient to be transfused blood from the pool of blood bank regardless of bringing replacement or not. But this can only happens if their was enough units stored in the blood bank, and in most cases their was non.

I have personally witnesses several cases where a patient can almost loose his/her life their donors travelling many kilometers only to be rejected due to mismatch. Imagine the money and time wasted! The blame is not on the healthcare personnel, nor on the government alone, the blame is on the system and our society at large. We are lacking altruism.

This problem can be attributed to the lack of decentralised system of blood banking we operate in Nigeria.
Nigeria has a single National blood donation system. While in places like US, procurement of blood is majorly met by volunteers, they have a pluralistic blood collection programs by ( Red cross, independent community blood centres,and hospitals).

In the US, 15 million units of blood are collected from 10 million donors annually, and only 7% are collected in hospitals, and 93% in regional centres, unlike Nigeria where most of the collection are done in hospitals.

In the US, the blood collection, processing, testing,and preservation are regulated by the FDA. They operated a sharing system where by blood units can be transferred from a region with less demand and higher collection to a region with more demand.

Blood transfusion data

Nigeria has a blood collection data problem, many hospitals especially in the rural areas can not keep the record consistently for a year. This problem can be attributed to the manual (pen and paper) system of health records we are still operating in Nigeria, which is subject to error, missing, or manipulation. Without proper blood collection data it would be difficult to alleviate problem of shortage, and implementation.

Lack of Awareness

A recent data has shown how blood donation is directly proportional to development; in developed countries, 50 units of blood are donated in every 1000 population. In developing countries, 15 units of blood are donated in every 1000 population. While in under developed countries, only 5 units of blood are donated in every 1000 population.

In under developed and developing countries, limited storage facilities, lack of incentives, malnutrition, personal wellbeing,and lack of knowledge can be a contributing factor to low turnout of voluntary blood donation. It’s more likely for a high income University graduate to donate blood voluntarily than a less educated poor labourer. The former might be healthier, more mentally stable, and more aware on the need to donate.

Expertise and Procurement Facilities

The current improvement in blood donation service especially in the tropics can be attributed to the benevolent funding by the US through USAID and President Emergency Plan For AIDS Relief (PEPFAR). Since 2000, there was continued efficiency in transfusion services in Nigeria, thanks to the aforementioned Agencies.

Despite this improvement, there was still problems of procedures, staff proficiency, specific testing,and preparation of separate blood components ( like plasma derivatives, platelets, and white blood cells).

Our screening methods are still qualitative immuno-phenotyping, we are using 4th generation ELISA ( Enzyme linked immunosorbent Assay), and no Nuclear Amplification Technique (NAT ) testing yet.

In 2018, I attended a two weeks training in Abuja organized by the University of Maryland experts under the supervision of Federal Ministry of Health (FMoH). We were trained on the standard serological techniques of Retro viral screening (RVS), Hepatitis, and VDRL. It was in preparation for a six month extensive survey we conducted across Nigeria based on the impact of HIV screening and therapy over the last three decades called Nigeria AIDS INDICATOR AND IMPACT SURVEY (NAIIS 2018). The training was an eye opener for me on the need to standardized our screening methods.

On a way forward, in order to attain the blood transfusion safety target, there is need for more voluntary donations campaign through mass media, schools, Churches, and Mosques.

Factors that prevent people from voluntary donations should be address like establishment of more independent blood donation centres, incentives, availability of storage facilities, and free donation services.
Nigeria should have a centralised registry of people with blood group O rhesus D negative, and such rare blood units should be made available across the country through a systematic sharing arrangement.

There is need for the communities and philanthropies to create more Non governmental organizations (NGOs) to address shortage of blood and to complement government efforts, as the government can not carryout the duty alone.

Saifullahi Attahir is the President of National Association of Jigawa State Medical Students (NAJIMS) National body. He wrote this piece from Federal University Dutse

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

WHX in Lagos 2026: Nigeria Open for Healthcare Investment—FG

Published

on

WHX in Lagos 2026

By Modupe Gbadeyanka

The federal government has urged global investors and innovators to tap into the Nigerian healthcare ecosystem, which is projected to grow by 7.1 per cent, reaching a market value of $161.7 million by 2027.

This advice was given by the Minister of State for Health and Social Welfare, Mr Isiaq Salako, at the opening of the World Health Expo (WHX in Lagos 2026), formerly known as Medic West Africa, on Tuesday in Lagos.

The broader West African market is expected to reach more than $11 billion, providing investors with an opportunity to get a good return on investment.

“Nigeria is open for healthcare investment. We want platforms like WHX in Lagos to serve as a critical conduit for translating this investment ambition into tangible technology access for our hospitals and patients,” the Minister, who declared the event open on behalf of President Bola Tinubu, said.

He praised the organisers of the expo, which welcomed over 8,000 healthcare professionals and 500 exhibitors spanning 40 countries, for growing the programme into a vital catalyst for West African healthcare transformation.

Addressing the stark reality that between 85 per cent and 99 per cent of medical equipment and in vitro diagnostics in West Africa are currently imported, Mr Salako outlined aggressive federal interventions designed to dismantle supply chain vulnerabilities and skyrocket local manufacturing capabilities.

He also spotlighted key presidential directives, including the Presidential Initiative to Unlock Healthcare Value Chains (PVAC) and the Presidential Executive Order for the Pharmaceutical and Allied Sectors, both engineered to catalyse health security, drive economic growth, and generate employment through strategic private-sector collaborations and Public-Private Partnerships (PPPs).

“Our commitment to improving access to modern equipment and technologies in hospitals is backed by concrete action. The government has inaugurated the $1.2 billion Sector-Wide Approach (SWAP) initiative, a comprehensive overhaul addressing financing, workforce development, and infrastructure.

“Furthermore, for the 2025 fiscal year, the Federal Government committed N402 billion specifically for health sector infrastructure investment,” he stated, also highlighting an expansive health infrastructure upgrade program in partnership with the Nigeria Sovereign Investment Authority (NSIA).

According to him, this phased initiative is actively delivering oncology and nuclear medicine centres across six tertiary hospitals, alongside establishing 22 modern medical diagnostic centres, seven cardiac catheterisation laboratories, and expanded radiology and clinical pathology capabilities distributed across Nigeria’s six geopolitical zones.

Also speaking, the chief executive of EHA Clinics, Dr Ifunanya Ilodibe, stressed the urgent need to support and unify fragmented growth within the healthcare system, noting that WHX serves as the precise ecosystem platform required to bring together policymakers, clinicians, and investors to move actionable strategies forward.

Also, the President of the Healthcare Federation of Nigeria (HFN) and Country Director of PharmAccess, Njide Ndili, said, “HFN bridges the gaps in health financing, opening up critical connections to achieve true health sovereignty,” praising Africa CDC’s historical intervention, particularly during the Ebola crisis and urged participants to utilise the WHX exhibition floor to forge collaborations capable of scaling locally produced medical equipment.

The Lagos State Commissioner for Health, Mr Akin Abayomi, on his part, highlighted the enforcement of the National Health Insurance Authority (NHIA) Act in Lagos State as a landmark regulatory milestone. The Act mandates health insurance for all residents, structuring the financial environment to guarantee medical protection across various socioeconomic levels.

Delivering the keynote address, the Special Regional Representative of the Director General of the Africa CDC Western Regional Coordinating Centre, Prof. Aliko Ahmed, called on leaders in geopolitical positions to enact liberating trade policies aligned with the African Continental Free Trade Area (AfCFTA) to shape the continental agenda, emphasising that the Africa CDC will fiercely prioritise building trust in locally manufactured healthcare products.

WHX in Lagos 2026 runs for three days, featuring accredited forums, cutting-edge product showcases, and high-level networking tracks designed to translate billions in public and private investment into immediate technology access for hospitals and patients.

Continue Reading

Health

Euracare Secures Court Order Halting Inquest into Chimamanda Son’s Death

Published

on

Euracare

By Adedapo Adesanya

The coroner’s inquest into the death of 21-month-old Nkanu Adichie-Esege, son of renowned author Chimamanda Ngozi Adichie, suffered a major setback on Wednesday after Euracare Multi-Specialist Hospital informed the coroner’s court that it had obtained an order of the Lagos State High Court staying further proceedings in the probe.

The matter came before Coroner Magistrate Atinuke Adetunji at Court 9, Igbosere Magisterial District, Yaba, Lagos, and was scheduled for the commencement of witness’ testimony.

Counsel to Euracare Multi-Specialist Hospital, Professor Taiwo Osipitan (SAN), told the court that the hospital had initiated judicial review proceedings challenging, among other issues, the jurisdiction of the Coroner’s Court to conduct the inquest in the absence of the deceased’s body.

He disclosed that the High Court had granted leave for the judicial review application and ordered that the leave operate as a stay of proceedings pending the determination of the suit.

The senior advocate also informed the court that although the Lagos State Attorney-General’s Office denied seeing the originating processes from the High Court, proof of service was available.

Responding on behalf of the family, Mr Kemi Pinheiro (SAN) confirmed receipt of both the originating processes and the High Court order.

While acknowledging the obligation of all parties to comply with court orders, he informed the coroner that the family had already filed four witness statements on oath, including that of Dr Ivara Esege, as well as statements from independent medical experts from Nigeria and the United States, who are expected to testify at the inquest.

Mr Pinheiro urged the court not to adjourn the matter indefinitely, but to a definite date after the court vacation to enable parties to report on developments in the High Court proceedings.

He also highlighted the need for transparency and public confidence in the fact-finding process, saying, “He who is innocent does not fear an open inquest.”

Counsel representing Atlantis Paediatric Hospital supported the request for a definite adjournment rather than an indefinite postponement.

Following submissions by counsel, the Coroner adjourned the matter until October 8, 2026, for a report on the status of the High Court proceedings.

Continue Reading

Health

Gavi Promises $50m for Bundibugyo Ebolavirus Vaccines

Published

on

Bundibugyo Ebolavirus Vaccines

By Modupe Gbadeyanka

About $50 million has been promised by Gavi, the Vaccine Alliance, through its First Response Fund (FRF), to support the response to the ongoing Bundibugyo ebolavirus outbreak.

A statement from the organisation made available to Business Post on Monday said up to $40 million would be available to enable accelerated access to investigational doses and, eventually, approved vaccines, while a further $10 million would support outbreak response and protection of routine immunisation services in impacted countries.

“We need to act now to ensure that, once one or more vaccine candidates are ready, manufacturers are in a position to start producing doses at scale,” the chief executive of Gavi, Dr Sania Nishtar, was quoted as saying.

“Leveraging this allocation, Gavi will work closely with CEPI and partners to design the right incentives to achieve this goal, exploring all options, including potential Advance Purchase Commitments.

“This effort, alongside ensuring emergency funds are on hand to support outbreak response and protect routine immunisation services in the communities impacted, is exactly what our First Response Fund was designed for,” Dr Nishtar added.

The First Response Fund is the only globally approved mechanism that allows “at-risk” financing for scaled-up production of vaccines under development. This means Gavi is able to make vital early investments even when development outcomes are uncertain.

The $40 million in immediate surge financing that has been approved today will enable manufacturers of the leading candidates of a vaccine against the Bundibugyo virus to directly commit to high-capacity manufacturing.

This, in turn, will ensure that, as soon as clinical trials demonstrate positive outcomes, investigational vaccine doses could be deployed rapidly to support outbreak response.

Looking to the longer-term, Gavi will also provide incentives for manufacturers to adopt the fastest pathways towards WHO Emergency Use Listing (EUL) and/or WHO Prequalification (PQ), which are critical global approvals that will enable the rapid use of these vaccines in future emergencies.

In the coming weeks, Gavi will finalise the design of a financial mechanism that leverages the $40 million FRF allocation to achieve these vaccine access goals, in close partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) as well as WHO, Africa Centres for Disease Control and Prevention (Africa CDC) and UNICEF.

The final design will take into account the characteristics of individual vaccine candidates and the needs of their manufacturers and may include mechanisms such as Advance Purchase Commitments. Work will also be undertaken to ensure successful candidates from African-based vaccine manufacturers can benefit from accelerated support through Gavi’s African Vaccine Manufacturing Accelerator (AVMA) initiative.

In addition to these investments, Gavi will also immediately release US$ 10 million to support countries and partners with outbreak response.

This funding will support implementation of national outbreak response plans, including targeted investments to protect routine immunisation, protect health care workers and ensure readiness for future vaccines. Gavi will work closely with countries, partners including Africa CDC, WHO, UNICEF, World Bank, and donors to ensure these investments complement other efforts.

Continue Reading

Trending